Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR001 in Pulmonary Arterial Hypertension
NCT01725256Phase 2Terminated
- Sponsor
- Aires Pharmaceuticals, Inc.
- Start
- Nov 2012
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of ferrous fumarate in pulmonary arterial hypertension (PAH), sponsored by Aires Pharmaceuticals, Inc.. Started Nov 2012; status: terminated.
02
Drugs
ferrous fumarate
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01725256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725256.